A single intra-articular injection of a novel extended-release triamcinolone acetonide formulation (FX006) has been shown to reduce pain in knee osteoarthritis for up to three months. The phase 3 trial of the microsphere-based formulation was compared to saline injections and a standard crystalline suspension of the steroid in almost 500 patients across 38 sites inclding ...
Microspheres keep IA steroids in place
By Mardi Chapman
25 Apr 2018